DGNOF
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | -0.01 | $15,750 | -$1M |
| 2025 Q3 | -0.01 | $15,193 | -$811,797 |
| 2025 Q2 | -0.01 | $15,159 | -$831,863 |
| 2025 Q1 | -0.01 | $19,402 | -$907,458 |
| 2025 Q4 | -0.01 | $18,392 | -$1M |
| 2024 Q3 | -0.01 | $26,042 | -$1M |
| 2024 Q2 | -0.01 | $22,673 | -$546,850 |
| 2024 Q1 | -0.01 | $36,690 | -$764,918 |